Related Experiment Video
Updated: Jun 22, 2026
04:09
Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
Published on: June 13, 2025
The treatment of CIN: what are the risks?
1Royal College of Surgeons in Ireland, Department of Gynaecology, Coombe and Tallagh Hospital, Dublin, Ireland. walter.prendiville@gmail.com
Summary
Treating squamous cervical intraepithelial neoplasia (CIN) involves removing the transformation zone (TZ). While excision offers benefits, large loop excision of the transformation zone (LLETZ) shows fewer risks than cone biopsy, especially for larger TZs.
Area of Science:
- Gynecology
- Oncology
- Public Health
Background:
- Squamous cervical intraepithelial neoplasia (CIN) treatment aims to remove or destroy the transformation zone (TZ).
- Excision methods for CIN are generally considered comparable in efficacy when performed correctly.
- Treatment thresholds for CIN may have lowered due to the perceived advantages of excision.
Purpose of the Study:
- To evaluate the risks associated with treatments for squamous cervical intraepithelial neoplasia (CIN).
- To compare pregnancy-related morbidity following different CIN excision methods.
- To assess the impact of transformation zone (TZ) size on treatment outcomes and risks.
Main Methods:
- Review of available evidence on treatments for squamous cervical intraepithelial neoplasia (CIN).
- Analysis of long-term pregnancy-related morbidity associated with excision procedures.
- Comparison of outcomes between cone biopsy and large loop excision of the transformation zone (LLETZ).
Main Results:
- Excision of the transformation zone (TZ) is the primary treatment for CIN.
- Cone biopsy is associated with increased serious adverse outcomes and premature labor compared to LLETZ.
- Large endocervical TZs increase risks of incomplete excision and premature labor.
Conclusions:
- Women with large type 2 and 3 TZs require thorough counseling before CIN treatment.
- The threshold for treating young women with mild abnormalities needs re-evaluation.
- LLETZ appears to have a better safety profile regarding pregnancy morbidity than traditional cone biopsy.
Related Concept Videos
01:28Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...